EMV's Principal Activity is the research and development of medical imaging and diagnostic technology previously licensed and subsequently acquired from Uniquest Pty Limited, for the purpose of commercialising a portable medical device for stroke diagnosis and monitoring as well as other medical imaging needs.
|Bid / Ask||-|
|Volume (4w avg)|
|vs Sector (1yr)||-3.31%|
|vs ASX 200 (1yr)||-21.63%|
|ASX Rank||736 of 2,319|
|Sector Rank||57 of 199|
EMvision Medical Devices Limited (EMV) is focused on the development and commercialisation of medical imaging technology. The Company is developing and seeking to commercialise a cost effective, portable, medical imaging device using electromagnetic microwave imaging for diagnosis and monitoring of stroke and other medical applications.
No incorporation details available.
DPS and Yield calculations use the Pay Date.
|Dr Phillip James Dubois||Non-Executive Director||Sep 2020||
Dr Phillip James Dubois
Dr Dubois is an imaging executive and neuroradiologist has joined the board as an independent Non-executive Director. Dr Dubois is a former CEO of their imaging division and served as Executive Director from 2001 to 2020. He is also the founder and former CEO and Chairman of Queensland X-Ray. Dr Dubois is currently an Associate Professor of Radiology at the University of Queensland Medical School. He has served on numerous government and radiology group bodies, including the councils of the Royal Australian and New Zealand College of Radiologists and the Australian Medical Association, and as Vice-President of the Australian Diagnostic Imaging Association. Dr Dubois is a Non executive Director of Magnetica Limited.
|Dr Ronald (Ron) Peter Weinberger||Chief Executive Officer,Managing Director||May 2020||
Dr Ronald (Ron) Peter Weinberger
Chief Executive Officer,Managing Director
Dr Weinberger has more than 20 years experience in medical research, biotechnology and commercialization. Dr Weinberger joined Nanosonics in August 2004 and was appointed as Executive Director in July 2008 then Managing Director and Chief Executive Officer December 2011 with a period as acting CEO from May 2011. From October 2013 to February 2018, Dr Weinberger was responsible for the direction of Nanosonics technology development and commercialisation strategy. He is coinventor of several of Nanosonics key technology patents.
|Mr Anthony (Tony) Keane||Non-Executive Director||Jun 2018||
Mr Anthony (Tony) Keane
Mr Keane is an experienced business and finance executive and holds a number of independent non executive director and advisory board roles. Mr Keane also undertakes finance advisory and consultancy assignments for various business clients and previously held numerous roles with a major trading bank principally in business, corporate and institutional banking. Mr Keane is currently an Independent Non-Executive Director of National Storage Holdings Ltd, the holding company established for National Storage REIT, the first independent, internally managed and fully-integrated owner and operator of selfstorage centres listed on the ASX and director of Queensland Symphony Orchestra Holdings Ltd, Queensland's largest performing arts company and only professional symphony orchestra. He is the Chair of Risk Committee.
|Mr John Keep||Non-Executive Chairman,Non-Executive Director||Mar 2018||
Mr John Keep
Non-Executive Chairman,Non-Executive Director
Mr Keep has public company board experience as well as senior management experience in the healthcare and hospitality sectors including managing start up enterprises and medical diagnostic companies. Mr Keep led the successful restructuring and revitalization of the radiology company Queensland Diagnostic Imaging, Queensland's leading private radiology and diagnostic imaging group and at Lemarne Healthcare, a company specialising in the detection and treatment of skin cancer. Mr Keep is a director of Queensland Symphony Orchestra Holdings Ltd and a member of that company's Finance Audit and Risk Committee.
|Mr Geoffrey (Geoff) Richard Pocock||Non-Executive Director||Mar 2018||
Mr Geoffrey (Geoff) Richard Pocock
Mr Pocock has experience as a corporate advisor and strategy consultant advising companies on commercialisation and IP management, business development, mergers and acquisitions strategy and raising equity capital from private and public equity markets. Mr Pocock is currently the principal of Polaris Consulting (WA) Pty Ltd. Mr Pocock previously spent several years as a research scientist in the biopharmaceutical industry in Australia and the United Kingdom. He is member of Risk Committee.
|Mr Scott Kirkland||Co-founder,Executive Director||Jul 2017||
Mr Scott Kirkland
Mr Kirkland has held several senior sales positions, including Head of Client Sales at Quantcast, a US-based technology company. Mr Kirkland is a co-founder of the Company and oversees its corporate affairs, commercial strategy and business development efforts.
|Ms Emma Waldon||Chief Financial Officer,Company Secretary||N/A|
EMV directors must report any change in shareholding to the ASX within 5 business days.
See Director Transactions for all ASX companies.
|14/04/21||Ronald (Ron) Weinberger||Buy||+17,200||$2.88||$49,534||On-market trade|
|07/12/20||Phillip Dubois||Issued||500,000||$3.34||$1,670,000||Issue of options|
|07/12/20||Ronald (Ron) Weinberger||Issued||1,000,000||$3.34||$3,340,000||Issue of options|
|01/12/20||Geoffrey (Geoff) Pocock||Buy||+5,000||$3.30||$16,500||On-market trade|
|01/10/20||Phillip Dubois||Buy||+40,000||$2.50||$100,000||Off-market trade|
|04/06/19||Ryan Laws||Buy||+14,844||$0.38||$5,641||On-market trade|
|03/06/19||Ryan Laws||Buy||+15,156||$0.368||$5,582||On-market trade|
|21/12/18||Scott Kirkland||Buy||+17,766||$0.304||$5,401||On-market trade|
|20/12/18||Scott Kirkland||Buy||+35,634||$0.303||$10,797||On-market trade|
|19/12/18||Geoffrey (Geoff) Pocock||Buy||+50,000||$0.301||$15,041||On-market trade|
The current holdings of EMV directors.
|Director||Last Notice||Direct Shares||Indirect Shares||Options||Convertibles|
|Geoffrey (Geoff) Pocock||30/06/2021||N/A||355,000||500,000||N/A|
|Anthony (Tony) Keane||30/06/2021||100,000||N/A||500,000||N/A|
|Ronald (Ron) Weinberger||30/06/2021||1,017,200||20,000||2,000,000||N/A|
A substantial shareholder is a person or entity that owns 5% or more of the voting shares in a company. Shares can be held through multiple entities, so the Substantial Shareholders list differs from the Top 20 Shareholders list.
Shareholding changes less than 1% do not require notification to the market. When all “Last Notice” dates are identical, it suggests that no (or minimal) change has occurred since the most recent Annual Report.
|Name||Last Notice||Total Shares||Shares Held (%)|
12 month transaction history compiled from ASX announcements.
No buy transactions reported by Substantial Shareholders in the past 12 months.
12 month transaction history compiled from ASX announcements.
|Date||Name||Sold||Previous %||New %|
|16-12-20||UniQuest pty Ltd||6,000,000||8.55||--|
All data on this page is supplied by the ASX, Morningstar and Market Index. Read the disclaimer.